OBTENCIÓN DE DEHIDRODIISOEUGENOL POR DIMERIZACIÓN DE ISOEUGENOL CON CULTIVOS CELULARES DE  Bouvardia ternifolia  (TROMPETILLA)

Hérnández-Vázquez, Liliana; Olivera-Flores, Ma. Teresa de Jesús; Luna, Héctor; Navarro‐Ocaña, Arturo

doi:10.1016/j.recqb.2017.04.002

Cited by 4 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…yield of DHIE (23%) was obtained with B. ternifolia [47]. In another study, DHIE was obtained from IE with B. ternifolia cultivated under nutritional stress, and H2O2 with a yield of 77% [48].…”

Section: Synthesis Of Dhie Derivativesmentioning

confidence: 99%

Synthesis and Biological Activities of Dehydrodiisoeugenol: A Review

et al. 2022

View full text Add to dashboard Cite

Dehydrodiisoeugenol (DHIE) is a neolignan found in more than 17 plant species, including herbs, fruit, and root. DHIE was, for the first time, isolated from Myristica fragrans bark in 1973. Since then, many methodologies have been used for the obtention of DHIE, including classical chemistry synthesis using metal catalysts and biocatalytic synthesis; employing horseradish peroxidase; peroxidase from Cocos nucifera; laccase; culture cells of plants; and microorganisms. Increasing evidence has indicated that DHIE has a wide range of biological activities: anti-inflammatory, anti-oxidant, anti-cancerogenic, and anti-microbial properties. However, evidence in vivo and in human beings is still lacking to support the usefulness potential of DHIE as a therapeutic agent. This study’s review was created by searching for relevant DHIE material on websites such as Google Scholar, PubMed, SciFinder, Scholar, Science Direct, and others. This reviews the current state of knowledge regarding the different synthetical routes and biological applications of DHIE.

show abstract

Section: Synthesis Of Dhie Derivativesmentioning

confidence: 99%

Synthesis and Biological Activities of Dehydrodiisoeugenol: A Review

et al. 2022

View full text Add to dashboard Cite

show abstract

“…It is estimated that around 50% of the drugs approved by the Federal Drug Administration are products derived from natural sources or analogs deriving from plants or microorganisms [26]. However, raw material can be limited, and its exploitation is one of the main ecological concerns.…”

Section: Products With Pharmaceutical Importancementioning

confidence: 99%

Modulation of Secondary Metabolites among Mexican Medicinal Plants by Using Elicitors and Biotechnology Techniques

Jiménez-Arellanes¹,

Pérez-González²

2022

Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications

View full text Add to dashboard Cite

Medicinal plants are being utilized as raw material and the use has increased in recent decades due that these biosynthesize compounds with several pharmacological activities. Some plant species with biological potential are of interest to the industry for preparation of drugs, phytodrugs, or food supplements. This causes overexploitation and deforestation, which endangers plant species-of-interest. In recent years, alternatives have been sought to eradicate this problem. A solution that was give and is maintained is plant biotechnology, which favors the production of active Secondary Metabolites (SMt). Plant biotechnology allows us to increase the yield of a compound-of-interest, reduces its production times and costs, and allows constant and controlled production of the raw material, and while aiding in the protection of medicinal plants that are found in danger of extinction. In the scientific literature, procuring the SMt by means of biotechnological processes is described, highlighting the study of four species from Mexican traditional medicine (Lopezia racemosa, Galphimia glauca, Cnidoscolus chayamansa, Sphaeralceae angustifolia and Buddleja cordata), and the main biological activities are as follows: anti-inflammatory, hepatoprotector, neuroprotector, anxiolytic, antitumoral, antibacterial, and antioxidant, among others.

show abstract

Biotechnological processes to obtain bioactive secondary metabolites from some Mexican medicinal plants

Pérez-González

Jiménez-Arellanes

2021

Appl Microbiol Biotechnol

View full text Add to dashboard Cite

OBTENCIÓN DE DEHIDRODIISOEUGENOL POR DIMERIZACIÓN DE ISOEUGENOL CON CULTIVOS CELULARES DE Bouvardia ternifolia (TROMPETILLA)

Cited by 4 publications

References 17 publications

Synthesis and Biological Activities of Dehydrodiisoeugenol: A Review

Synthesis and Biological Activities of Dehydrodiisoeugenol: A Review

Modulation of Secondary Metabolites among Mexican Medicinal Plants by Using Elicitors and Biotechnology Techniques

Biotechnological processes to obtain bioactive secondary metabolites from some Mexican medicinal plants

Contact Info

Product

Resources

About